Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. - Wikidata - awgldk - TriplyDB

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.

http://www.wikidata.org/entity/Q40576862

about

Translating pharmacogenomics: challenges on the road to the clinic Chapter 7: Pharmacogenomics Pharmacogenetics of beta-blockers Personalized medicine and treatment approaches in hypertension: current perspectives Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders Pharmacogenetics and anaesthesia: the value of genetic profiling Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation Pharmacogenomics of hypertension and heart disease Pharmacogenomics and drug response in cardiovascular disorders Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survival.GRK5 Gln41Leu polymorphism is not associated with sensitivity to beta(1)-adrenergic blockade in humans.The Pharmacogenomics of Anti-Hypertensive Therapy Pharmacogenetics of antihypertensive treatment: detailing disciplinary dissonance Beta-blocker pharmacogenetics in heart failure.Improved understanding of the pathophysiology of atrial fibrillation through the lens of discrete pathological pathways Polymorphisms in α- and β-Adrenergic Receptor Genes, Hypertension, and Obstructive Sleep Apnea: The Skaraborg Sleep Study.G protein-coupled receptor kinase 5 gene polymorphisms are associated with postoperative atrial fibrillation after coronary artery bypass grafting in patients receiving β-blockers Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review.β2 adrenergic receptor polymorphisms and nocturnal blood pressure dipping status in the Wisconsin Sleep Cohort Study.Effect of the ADRB1 1165C>G and 145A>G polymorphisms on hemodynamic response during dobutamine stress echocardiography.Pharmacogenomics: the genetics of variable drug responses.PharmGKB summary: very important pharmacogene information for angiotensin-converting enzyme.Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals Cardiovascular pharmacogenomics of adrenergic receptor signaling: clinical implications and future directions Impact of polymorphic variants on the molecular pharmacology of the two-agonist conformations of the human β1-adrenoceptor.Progress and future aspects in genetics of human hypertension Cardiovascular pharmacogenomics Genetic variation, β-blockers, and perioperative myocardial infarction.The functional significance of genetic variation within the beta-adrenoceptor.Pharmacogenomics of adrenoceptors.A case for pharmacogenomics in management of cardiac arrhythmias.Emerging strategies and applications of pharmacogenomics G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.Role of cytochrome P450 genotype in the steps toward personalized drug therapy.Pharmacogenetics of chronic cardiovascular drugs: applications and implications.Neurohumoral activation in heart failure: the role of adrenergic receptors.Hypertension pharmacogenomics: in search of personalized treatment approaches

P2860

Q21092371-986EB117-3DF1-4769-8CB3-6BE83C903507 Q21563496-64BC521E-FE91-4FF3-9050-725322110CB4 Q24644448-FD4ED54E-4CBE-4719-81F6-C25FF10EE4E8 Q26751135-F58B8B01-88E3-4EA2-BCE0-8612974A7AAA Q26753129-8E73E516-56EB-4F62-B4D7-30F32A2DE289 Q26859221-A6652F78-1335-4F33-9F56-17B44D78318C Q27011524-7199A343-0B58-4BF6-87DE-3CF00D653BA7 Q27015722-D7F74AC4-3E77-4857-857B-17ABAE6C3E47 Q28171051-9BA878E6-CADC-44FA-B53E-2B8BAA03B386 Q30478644-1DC4323C-FA22-424C-83F7-C92ECDC02FF8 Q33378995-B5B92861-1485-4257-BB12-C08153E7D690 Q33646237-06ABDD55-97AB-44DE-BA3F-DF837720AA0A Q33664144-E57A65D2-B5A2-43B7-89D0-BA9018193119 Q33776918-CF07168B-4C39-4CFF-8AA7-8CEC4F330C57 Q33778169-B59DC12E-A0D4-4244-9E01-39B8F819EBCF Q33923776-F51BDC95-D762-455C-A64A-657C71EB8F07 Q34170701-41BEFBFF-9578-4AA8-9FEA-F7A114618F15 Q34735239-068AAF0A-1288-4EB1-9783-6A0CA60B391D Q34747512-5BA6499D-50B9-4405-9D50-B1AFC90E210F Q34766294-4823B644-AC4D-4115-8A02-47AE7D62CBB4 Q34792411-88C10861-CE51-45CD-B58E-B300CC14C24F Q34976915-8DB9FAF4-7615-4CA5-9549-E32D5702F2D2 Q34994915-E12DCEF8-E87F-4980-81C6-9F494466B39D Q34997022-14AF350A-D171-4DD5-99DD-93F9CC982F53 Q35033003-4E02A6A3-9DA6-40D6-AB52-677CBA2BDC2B Q35046547-A3A35B69-6C42-4FBF-B3F1-B34CF121FE97 Q35202339-77D26D9B-6B1E-4932-A7A4-3C9CF45237E5 Q35447163-8BA0F76A-1DCB-4A80-A13F-7E7B3FA6728B Q35580952-0E5388E3-7422-4DF3-B8F7-FBAAF8A36CE1 Q35826772-9F65402F-A8BD-4999-8D9F-8ECD08F1BD25 Q35911140-AEA9A75D-A01C-4B1E-9E8C-9809EA2C7757 Q35914690-6AF727EC-8A75-439B-A77F-6B3EB2691BDA Q35988130-CC0FBE12-CDBF-419C-BE1C-DE80DD71394F Q36291684-E4A23158-36C5-41D8-9664-B9DEB2926C85 Q36316001-1962FFE9-FD01-4B20-95F7-AD098B9C1343 Q36326202-9F868703-918E-4384-A369-58A4B59E800B Q36441521-7C2FCFE2-28D2-4E92-B6FE-C3AB9A4548F0 Q36543128-2BE8B651-69ED-4835-8FE3-B45AD3AF867C Q36579463-DB2DF021-C76B-48C6-B8A3-1A6DBDBCCFA0 Q36652960-FA1A9CAC-6684-4B8F-BA14-575E6C297321

P2860

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.

http://www.wikidata.org/entity/Q40576862

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.

@en

type

label

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.

@en

prefLabel

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.

@en

P1433

Q40576862-1CB0FECC-B5ED-4C26-A49C-D5B7420BE730

P1476

Q40576862-3D009762-581D-467F-AA8E-839BE5C6C6D6

P2093

Q40576862-57F68969-EBD9-41DA-A0CB-98AD4A94D3E2

Q40576862-5B8B0170-639B-474D-8437-E4CACE43DFFE

Q40576862-5C948500-7F24-43C4-A23B-BF7EC0644C2A

Q40576862-6F040A20-32D7-4404-8435-91B09FBAE2C9

Q40576862-7F7FFDAF-C910-4A19-91A8-6CEBF23FCBF7

Q40576862-C072D4A0-0702-4C69-91F3-8A571207DCBD

P304

Q40576862-DAE0CA71-AB1B-4F04-98F2-26535F3D0AFB

P31

Q40576862-87928788-F809-42E4-8950-E58C6BB16BCA

P356

Q40576862-A99312AD-421E-4CEB-8C8B-F37BD2FFE5C2

P407

Q40576862-4E2024E1-B5B6-45C0-A0A9-040329515494

P433

Q40576862-936C5372-079F-4675-8CF6-8333BF0C179E

P478

Q40576862-6F6A6AF6-EFC2-4E2F-98D7-A2828E78AD4D

P577

Q40576862-273804DB-F4EC-4475-994B-6D76A92E9A1E

P698

Q40576862-B830DBE1-6DA4-4449-9A16-8897D214FCD8

P356

S0009-9236(03)00068-7

P1433

Clinical Pharmacology & Therapeutics

P1476

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.

@en

P2093

Brian J Puckett

http://www.w3.org/2001/XMLSchema#string

Daniel F Pauly

http://www.w3.org/2001/XMLSchema#string

Hossein N Yarandi

http://www.w3.org/2001/XMLSchema#string

Issam Zineh

http://www.w3.org/2001/XMLSchema#string

Julie A Johnson

http://www.w3.org/2001/XMLSchema#string

Susan P McGorray

http://www.w3.org/2001/XMLSchema#string

P304

44-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0009-9236(03)00068-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12844134

http://www.w3.org/2001/XMLSchema#string